HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki



In this video we're gonna be performing a deep dive on Abbott Labs dividend safety to begin let's talk about Abbott Labs business model Abbott Labs is one of the largest medical appliances and equipment manufacturers in the world only Johnson & Johnson which also has other businesses such as pharmaceuticals has. A higher market capitalization Abbott Labs was founded in 1888 and has grown into. A company valued at a hundred and twenty billion dollars Abbott Labs is a well known dividend stock because of its compelling track record of dividend growth with 46 years. Of consecutive dividend increases Abbott Labs is a member of the dividend aristocrats Index a group of elite dividend stocks with more than 25 years of consecutive dividend increases looking ahead investors cannot rely on Abbott Labs dividend. History alone to measure its dividend safety for the remainder of this video we will discuss the company's current dividend safety from four perspectives its dividend safety in the context of its current earnings its dividend safety in the context. Of its current free cash flow its dividend safety in the context of its recession. Performance and its dividend safety in the context of its current debt load first let's discuss Abbott Labs dividend safety in the context. Of the company's current earnings when Abbott Labs reported third quarter financial results on October 17th the company announced that it generated adjusted earnings. Per share of 75 cents in the three month reporting period for context Abbott Labs currently pays a quarterly dividend of Toni eight cents per share for a pea ratio of 37 percent in the most recent quarter looking out over a longer time horizon our conclusion is the same Abbott Labs generated two dollars and seven cents. Of adjusted earnings per share through the first nine months of fiscal 2018 and. Paid 84 cents of common share dividends during the same time period for a dividend payout ratio of 41 percent using earnings abbott labs dividend appears very safe for the foreseeable future many analysts believe that comparing a company's dividend payments to its free. Cash flow is a better method for assessing dividend. Safety with that in mind we will now compare abbott labs current dividend payments to its free cash flow. Through the first nine months of fiscal 2018 abbott labs generated 4.5 billion dollars of cash from operating activities and spent nine hundred and twenty seven million dollars on capital expenditures for free cash flow of 3.6 billion dollars the company distributed 1.5 billion dollars. Of common share dividends during the same time period for a free cash flow dividend pay ratio of 42 percent using free cash flow our conclusion is the same as when we use earnings to measure Abbott Labs dividend safety although a second. Level analysis was required the company's dividend appears safe for the foreseeable future companies do not cut their dividends in the good times instead dividends are reduced when companies experience financial difficulties with that in mind this section will analyze Abbott Labs current dividend safety in the context. Of the company's historical recession performance we believe that the best way to measure a company's recession resiliency is by assessing its earnings per share performance during the financial crisis that occurred. Between 2007 and 2009 I believes performance during this time period is shown here Abbott Labs earnings per share continued their streak of uninterrupted increases during the 2007 to 2009 recession with that in mind we have no concerns about the company's ability to pay. Rising dividends during future economic contractions the last angle that we will use to assess Abbott Labs current dividend safety is by looking at the company's current debt level more specifically we will see how. Much the company's weighted average. Interest rate would need to increase before its free cash flow will no longer cover its dividend payment through the first nine months of fiscal 2018 abbott labs generated six hundred and forty million. Dollars of interest expense and had twenty three point three billion dollars of debt outstanding for a weighted average interest rate of three point seven percent the following image shows how changes to Abbott Labs weighted average interest rate would impact the company's dividend safety as measured by free cash flow as the image shows abbott labs weighted average interest. Rate would need to rise to approximately the 16% level before its dividend would no longer be covered by free cash flow with that in mind we believe that the company's debt level is unlikely to impact the safety of its dividend moving forward thank you. For watching today's video which performed a deep dive on Abbott Labs current dividend safety we invite you to subscribe to this channel and like this video which will help more people discover sure dividends investor education efforts if you're interested in. Learning more about our. Systematic approach to dividend growth investing visit. Our website.

 


Abbott Laboratories Company News

Wed, 08 May 2019 17:51:00 GMT
Abbott Laboratories: A Solid Business For An Attractive Valuation - Seeking Alpha
<ol><li> Abbott Laboratories: A Solid Business For An Attractive Valuation Seeking Alpha</font></li><li><a href="/url/?u=https://www.finbulletin.com/2019/05/09/gunning-for-the-success-abbott-laboratories-abt-etsy-inc-etsy/" target="_blank">Gunning for the success: Abbott Laboratories (ABT), Etsy, Inc. (ETSY) FinBulletin</font></li><li><a href="/url/?u=https://www.finmercury.com/2019/05/09/expensive-market-what-to-buy-two-harbors-investment-corp-two-abbott-laboratories-abt/" target="_blank">Expensive Market, What To Buy? Two Harbors Investment Corp. (TWO), Abbott Laboratories (ABT) Financial Mercury</font></li><li><a href="/url/?u=http://www.stockmarketstop.com/2019/05/watch-the-active-stock-move-abbott-laboratories-abt/" target="_blank">Watch the Active stock Move— Abbott Laboratories (ABT) Stock News Stop</font></li><li><a href="/url/?u=https://postanalyst.com/2019/05/08/investors-brace-for-impact-hp-inc-hpq-abbott-laboratories-abt/" target="_blank">Investors Brace For Impact: HP Inc. (HPQ), Abbott Laboratories (ABT) Post Analyst</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlENzVqempZQU1FZlF5X0ppeVNneTFLQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Mon, 06 May 2019 13:30:00 GMT
Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year? Yahoo Finance Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Abbott Laboratories (ABT) been one of ...
Thu, 09 May 2019 11:41:51 GMT
May 09, 2019 - Inverness Counsel Inc Buys Abbott Laboratories, Verizon Communications Inc, Darden Restaurants Inc, Sells Danaher Corp, Union Pacific Corp, Activision Blizzard Inc - GuruFocus.com
May 09, 2019 - Inverness Counsel Inc Buys Abbott Laboratories, Verizon Communications Inc, Darden Restaurants Inc, Sells Danaher Corp, Union Pacific Corp, Activision Blizzard Inc GuruFocus.com Investment company Inverness Counsel Inc buys Abbott Laboratories, Verizon Communications Inc, Darden Restaurants Inc, Applied Materials Inc, Vertex ...
Thu, 09 May 2019 13:53:32 GMT
Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases | Abbott Laboratories, AbbVie Inc., Biomerieux, Inc. | - Medgadget
Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases | Abbott Laboratories, AbbVie Inc., Biomerieux, Inc. | Medgadget Sexually Transmitted Diseases Industry Description Wiseguyreports.Com Adds “Sexually Transmitted Diseases -Market Demand, Growth, Opportunities and.
Thu, 09 May 2019 05:42:40 GMT
Hospital Acquired Infection Control Market– Abbott Laboratories, Bayer AG, Alere Inc.,Dickinson and Company - StockNewsMagazine
Hospital Acquired Infection Control Market– Abbott Laboratories, Bayer AG, Alere Inc.,Dickinson and Company StockNewsMagazine The Hospital Acquired Infection Control report helps you achieve your dream of an outshining and winning business. Hospital Acquired Infection Control report ...
Tue, 16 Apr 2019 07:00:00 GMT
Abbott Laboratories Q1 2019 Earnings Preview - Seeking Alpha
Abbott Laboratories Q1 2019 Earnings Preview Seeking Alpha Abbott Laboratories (NYSE:ABT) is scheduled to announce Q1 earnings results on Wednesday, April 17th, before market open. The consensus EPS Estimate is ...
Thu, 09 May 2019 10:12:39 GMT
Osmotic Laxative Market to See Major Growth by 2024 | Abbott Laboratories, Alimentary Health, Edusa Pharmaceuticals, Ironwood Pharmaceuticals - MajoReports
Osmotic Laxative Market to See Major Growth by 2024 | Abbott Laboratories, Alimentary Health, Edusa Pharmaceuticals, Ironwood Pharmaceuticals MajoReports A new business intelligence report released by HTF MI with title “Southeast Asia Osmotic Laxative Market Report (2014-2024) – Market Size, Share, Price, Trend ...
Thu, 09 May 2019 07:56:24 GMT
Global Sample Collection Devices Market 2019 – 3M Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., FL MEDICAL s.r.l. - Market News 24
Global Sample Collection Devices Market 2019 – 3M Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., FL MEDICAL s.r.l. Market News 24 Global Sample Collection Devices Market Research Report comprises holistic business information and changing trends in the market that enables users to spot ...
Sat, 20 Apr 2019 07:00:00 GMT
Bulls And Bears Of The Week: Abbott Labs (NYSE:ABT), Chevron (NYSE:CVX), CVS (NYSE:CVS), United (NYSE:UAL) And More - Benzinga
Bulls And Bears Of The Week: Abbott Labs (NYSE:ABT), Chevron (NYSE:CVX), CVS (NYSE:CVS), United (NYSE:UAL) And More Benzinga Benzinga has examined prospects for many investor favorite stocks over the past week. Bullish calls included a leading airline and a pharmaceutical ...
Thu, 09 May 2019 10:53:15 GMT
Global Pap Test Sales Market 2019 – Abbott Laboratories, Arbor Vita Corporation, BD, Femasys Inc., Hologic, Inc., Onco Health - Industry News Updates USA
Global Pap Test Sales Market 2019 – Abbott Laboratories, Arbor Vita Corporation, BD, Femasys Inc., Hologic, Inc., Onco Health Industry News Updates USA The Global Pap Test Sales Market report presents an in-depth assessment of the Market Research including Technologies, Landscape, Strategies, inventory ...